Biotech activity is booming throughout the western world and the Asia (Singapore/Japan)where the highest standards can be demanded. Not only that but the big pharmas are positioning themselves for the wave of aged related health care demands, and suitable locations where the best production environments and tax regimes exist. Just read Astra Zeneca/Pfizer and you might start to get the picture.
Now MSB is no different; you might have noticed that the Aust Government - who are already providing MSB incentive dollars for research conducted here - are doing a noticeable amount of hand holding with the CEO lately.
Sure the Lonza Singapore facility arrangement was signed in 2011 giving MSB a number of options to go forward in time. A year or so later the FDA approved Lonza Singapore as a suitable facility to supply the required MPC's (into the USA) for the Stage 3 heart trials. That naturally went ahead in due course and Lonza are no doubt happy they seem to be at the front in terms of partnership with MSB.
MSB could turn their back on Lonza anytime and jump in with another production house (unlikely but legal) and thereby lose access to their well known expertise, some of it exclusive. But they haven't.
Are you getting a picture here: that very big deals involving major global corporations and governments in complex fields need to move step by step. This is not like setting up a pie cart at the MCG and buying the sauce on the way to the ground; it is a massive enterprise that must be mistake free.
Kakala, I hope you have played or watched chess in your life sometime. When playing for a six pack you can throw the pieces around. When playing for the farm, a careless move could result in divorce. But playing for a place in the biotech space is not for the faint of heart - especially when disruptive forces like one nutter bank analyst and their grizzly profit machine are working against you in your own country (I smell sour grapes there - maybe a jilted lover sort of).
Please, give the professor a break or bale out of the stock or bale out of the thread. There is nothing wrong with this announcement, it is telling you that Singapore is moving from the thinking to the doing on a bigger scale. I could be wrong but he is practically telling you that positive results are coming.
As for the Singapore incentive dollars, for god's sake grow up - you and pa31(a few bob short)expect MSB to shovel this information out the door just to keep you happy?
Lift your game.
Banana
MSB Price at posting:
$4.89 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)